No abstract

No abstract

Given image labels as the only supervisory signal, we focus on harvesting, or mining, thoracic disease localizations from chest X-ray images. Harvesting such localizations from existing datasets allows for the creation of improved data sources for computer-aided diagnosis and retrospective analyses. We train a convolutional neural network (CNN) for image classification and propose an attention mining (AM) strategy to improve the model's sensitivity or saliency to disease patterns. The intuition of AM is that once the most salient disease area is blocked or hidden from the CNN model, it will pay attention to alternative image regions, while still attempting to make correct predictions. However, the model requires to be properly constrained during AM, otherwise, it may overfit to uncorrelated image parts and forget the valuable knowledge that it has learned from the original image classification task. To alleviate such side effects, we then design a knowledge preservation (KP) loss, which minimizes the discrepancy between responses for X-ray images from the original and the updated networks. Furthermore, we modify the CNN model to include multi-scale aggregation (MSA), improving its localization ability on small-scale disease findings, e.g., lung nodules. We experimentally validate our method on the publicly-available ChestX-ray14 dataset, outperforming a class activation map (CAM)-based approach, and demonstrating the value of our novel framework for mining disease locations.

No abstract

Artificial intelligence-based tools designed to assist in the diagnosis of lymphoid neoplasms remain limited. The development of such tools can add value as a diagnostic aid in the evaluation of tissue samples involved by lymphoma. A common diagnostic question is the determination of chronic lymphocytic leukemia (CLL) progression to accelerated CLL (aCLL) or transformation to diffuse large B-cell lymphoma (Richter transformation; RT) in patients who develop progressive disease. The morphologic assessment of CLL, aCLL, and RT can be diagnostically challenging. Using established diagnostic criteria of CLL progression/transformation, we designed four artificial intelligenceconstructed biomarkers based on cytologic (nuclear size and nuclear intensity) and architectural (cellular density and cell to nearest-neighbor distance) features. We analyzed the predictive value of implementing these biomarkers individually and then in an iterative sequential manner to distinguish tissue samples with CLL, aCLL, and RT. Our model, based on these four morphologic biomarker attributes, achieved a robust analytic accuracy. This study suggests that biomarkers identified using artificial intelligence-based tools can be used to assist in the diagnostic evaluation of tissue samples from patients with CLL who develop aggressive disease features.